뉴스
- 국산 비만치료제, 해외서 긍정적 임상평가 회사는 내년 상반기 임상시험계획(IND) 제출을 목표로 하고 있다.CT-G32는 GLP-1을 포함한 4개 타깃에 동시에 작용하는 차세대 비만치료제이다. 간앤리는 한국 내 임상시험계획(IND) 승인과 품목허가에 필요한 규제 자료를 제공하고 관련 업무에 협력한다.JW중외제약은 간앤리에 계약금 500만 달러와 단계별 마일스톤 7610만
- School Superintendents Are Superstressed Parents in Carmel, Ind., likened the recent hire of a diversity, equity and inclusion officer to Nazi
- 2020 Democratic Debate: Highlights From Nevada former Mayor Pete Buttigieg of South Bend, Ind.; and Senator Amy Klobuchar of Minnesota....
- DealBook: Will It Be Billionaire vs. Billionaire in the 2020 Election? Bend, Ind. seats in... voted to ban cellular carriers from using federal subsidies to buy equipment from Huawei and
- Bernie Sanders Has a Heart Attack: This Week in the 2020 Race 6 million Mayor Pete Buttigieg of South Bend, Ind.: $19.1 million Former Vice President Joseph... weapons ban, gun licensing and other measures.